Loading clinical trials...
Loading clinical trials...
PD-1 inhibitor （Pembrolizumab, 2mg/kg weight, once per 4 weeks and 3 times of medication usage）treatment on AIDS patients with progressive multifocal leukoencephalopathy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
First Affiliated Hospital of Zhejiang University
NCT07032363 · Depression, HIV, and more
NCT04378439 · HIV/AIDS, STI, and more
NCT06741631 · HIV/AIDS
NCT06741618 · HIV/AIDS
NCT01206920 · HIV, AIDS
the first affiliated hospital of Zhejiang university school of medicine
Hangzhou, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions